Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             24 results found
no title author magazine year volume issue page(s) type
1 A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis Saida, T
2012
18 9 p. 1269-1277
article
2 Assessing brain connectivity at rest is clinically relevant in early multiple sclerosis Faivre, Anthony
2012
18 9 p. 1251-1258
article
3 Central nervous system aquaporin-4 autoimmunity presenting with an isolated cerebral abnormality Kim, Su-Hyun
2012
18 9 p. 1340-1343
article
4 Characteristics of multiple sclerosis in aboriginals living in British Columbia, Canada Saeedi, Jameelah
2012
18 9 p. 1239-1243
article
5 Estimating the prevalence and incidence of multiple sclerosis in the Lorraine region, France, by the capture–recapture method El Adssi, Haritina
2012
18 9 p. 1244-1250
article
6 Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis Kümpfel, T
2012
18 9 p. 1229-1238
article
7 High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women Hedström, Anna K
2012
18 9 p. 1334-1336
article
8 Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort Lebrun, C
2012
18 9 p. 1297-1302
article
9 Increased radial diffusivity in spinal cord lesions in neuromyelitis optica compared with multiple sclerosis Klawiter, Eric C
2012
18 9 p. 1259-1268
article
10 Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: Commentary Hutchinson, Michael
2012
18 9 p. 1213-1214
article
11 Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: No Weinshenker, Brian G
2012
18 9 p. 1211-1212
article
12 Industrial pharmaceutical drug research has done more for the health of people with MS than academic neurologists: Yes Havrdová, Eva
2012
18 9 p. 1209-1210
article
13 Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years Confavreux, Christian
2012
18 9 p. 1278-1289
article
14 MRI-based analysis of the natalizumab therapeutic window in multiple sclerosis Grimaldi, Luigi ME
2012
18 9 p. 1337-1339
article
15 Multiple sclerosis and progressive resistance training: a systematic review Kjølhede, T
2012
18 9 p. 1215-1228
article
16 Platform Presentations 2012
18 9 p. S5-S10
article
17 Poster Presentations 2012
18 9 p. S10-S23
article
18 Prelims for ACTRIMS 2012
18 9 p. 1345-1346
article
19 Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials Benedict, Ralph HB
2012
18 9 p. 1320-1325
article
20 Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia Marrie, Ruth Ann
2012
18 9 p. 1310-1319
article
21 The relation between cognitive and motor dysfunction and motor imagery ability in patients with multiple sclerosis Heremans, Elke
2012
18 9 p. 1303-1309
article
22 The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome Young, CA
2012
18 9 p. 1326-1333
article
23 Time-patterns of annualized relapse rates in randomized placebo-controlled clinical trials in relapsing multiple sclerosis: A systematic review and meta-analysis Nicholas, Richard
2012
18 9 p. 1290-1296
article
24 Trigger, pathogen, or bystander: the complex nexus linking Epstein– Barr virus and multiple sclerosis Owens, Gregory P
2012
18 9 p. 1204-1208
article
                             24 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands